51黑料吃瓜在线观看,51黑料官网|51黑料捷克街头搭讪_51黑料入口最新视频

設(shè)為首頁 |  加入收藏
首頁首頁 期刊簡介 消息通知 編委會 電子期刊 投稿須知 廣告合作 聯(lián)系我們
胍基抗菌材料在糖尿病動物皮膚創(chuàng)傷中的抗菌性能研究

Antibacterial properties of guanidine materials on wounds of diabetic animal skin

作者: 邱浩峰  馮培培  駱陽  吳徐金  侯文佳  牟賢波竺亞斌 
單位:寧波大學(xué)醫(yī)學(xué)院(浙江寧波 315211)
關(guān)鍵詞: 聚六亞甲基胍;胍基聚合物;  糖尿病;  皮膚創(chuàng)傷;  抗菌 
分類號:R318.08
出版年·卷·期(頁碼):2020·39·3(233-243)
摘要:

目的 糖尿病可以引起多種并發(fā)癥,皮膚潰瘍、潰爛是常見癥狀,并且經(jīng)久不愈。因此,本研究擬制備一種性能優(yōu)異的胍基抗菌材料,以對糖尿病患者皮膚潰瘍、潰爛的治療提供參考。方法 首先將鹽酸胍與己二胺發(fā)生聚合反應(yīng),合成具有良好抗菌性能的系列聚六亞甲基胍(polyhexamethylene guanidine,PHMG),并用紅外光譜分析檢測PHMG的分子結(jié)構(gòu);然后對其進(jìn)行抗菌性能檢測,菌種包括大腸桿菌、耐甲氧西林金黃色葡萄球菌MRSA USA300、銅綠假單胞菌PAO1和PGO2330;最后,構(gòu)建糖尿病模型小鼠,并造成小鼠皮膚損傷,在未染菌和感染金黃色葡萄球菌(MRSA USA300)兩種情況下,對PHMG的殺菌和抗感染性能進(jìn)行研究。結(jié)果 聚合反應(yīng)發(fā)生,成功合成系列PHMG。其中,PHMG5對上述4種細(xì)菌具有很好的抗菌效果。動物實(shí)驗(yàn)證明,PHMG5對于糖尿病小鼠皮膚傷口具有顯著抗菌性能。結(jié)論 通過聚合反應(yīng)可以合成系列聚六亞甲基胍,該胍基聚合物具有良好的抗菌性能,有利于糖尿病小鼠傷口的抗感染。

Objective Severe diabetic patients are always accompanied by refractory skin ulceration, since the patients possessed abnormal insulin regulation and weak immunity which leaded to the poor resistance to foreign microorganism infection. Therefore, the purpose of this study is to synthesize a guanidine-based material with excellent antibacterial properties, which will be valuable for the treatment of diabetic skin ulcers in future. Methods Polyhexamethylene guanidines (PHMGs) with good antibacterial properties were synthesized based on the polymerization reaction of guanidine diamine with hexamethylenediamine under appropriate conditions. The molecular structure of PHMG was detected by infrared spectrum analysis. Subsequently, the antibacterial properties of these materials to common bacteria were tested. The strains include: Escherichia coli(E. coli), methicillin-resistant Staphylococcus aureus (MRSA USA300), Pseudomonas aeruginosa (PAO1 and PGO2330). On this basis, diabetic mice were constructed to simulate the skin damage of clinically diabetic patients. The bactericidal and anti-infection properties of PHMGs were investigated via S. aureus MRSA USA300 diabetic wound infection model in mice. Results Infrared spectroscopy confirmed the occurrence of the polymerization reaction. The minimum bacteriostatic concentration and bacteriostatic zone experiments showed that PHMGs had good bacteriostatic effects on the above four kinds bacteria. The in vivo experiment verified that PHMGs had significant inhibitory effects on skin wounds of diabetic mice. Conclusions A series of polyhexamethylene guanidine were synthesized through polymerization between guanidine diamine and hexamethylenediamine. The guanidine-based polymer has good bacteriostatic properties and is beneficial to the anti-infection of wounds in diabetic mice.

參考文獻(xiàn):

1. Fang RC, Galiano RD. A review of becaplermin gel in the treatment of diabetic neuropathic foot ulcers[J]. Biologics: Targets & Therapy, 2008, 2(1): 1-12.

2. Pradhan L, Cai X, Wu S, et al. Gene expression of pro-inflammatory cytokines and neuropeptides in diabetic wound healing[J]. The Journal of Surgical Research, 2011, 167(2): 336-342.

3. Papanas N, Maltezos E. Becaplermin gel in the treatment of diabetic neuropathic foot ulcers[J]. Clinical Interventions in Aging, 2008, 3(2): 233-240.

4. Das S, Baker AB. Biomaterials and nanotherapeutics for enhancing skin wound healing[J]. Frontiers in Bioengineering & Biotechnology, 2016, 31(4): article 82.

5. TakenakaH, YasunoH, KishimotoS, et al. 成纖維細(xì)胞生長因子受體在人正常皮膚和傷口處的免疫定位[J]. 國際皮膚性病學(xué)雜志, 2004, 30(1): 47-47.

TakenakaH, YasunoH, KishimotoS, et al. Immunolocalization of fibroblast growth factor receptor in normal human skin and wounds[J]. International Journal of Dermatology and Venereology, 2004, 30(1): 47-47.

6. Falcone DJ, Khan KM, Layne T, et al. Macrophage formation of angiostatin during inflammation[J]. The Journal of Biological Chemistry, 1998, 273(47): 31480-31485.

7. Luo J, Yang Z. Preparation of fibrin glue and application in tissue engineering[J]. Journal of Biomedical Engineering Research, 2005, 23(3): 187-189.

8. Rippa AL, Kalabusheva EP, Vorotelyak EA. Regeneration of dermis: scarring and cells involved[J]. Cells, 2019, 8(6): 607.

9. Bielefeld KA, Amini-Nik S, Alman BA. Cutaneous wound healing: recruiting developmental pathways for regeneration[J]. Cellular & Molecular Life Sciences, 2013, 70(12): 2059-2081.

10. Miyan JA, Broome CS, Afan AM. Coordinated host defense through an integration of the neural, immune and haemopoietic systems[J]. Domestic Animal Endocrinology, 1998, 15(5): 297-304.

11. Triantafilou M, Brandenburg K, Kusumoto S, et al. Combinational clustering of receptors following stimulation by bacterial products determines lipopolysaccharide responses[J]. Biochemical Journal, 2004, 381(Pt 2): 527-36.

12. 楊偉國, 居軍. 糖尿病患者免疫功能狀態(tài)研究[J]. 國際檢驗(yàn)醫(yī)學(xué)雜志, 2011, 32(7): 768-769.

Yang WG, Ju J. The study for immunologic function of diabetic patient[J]. International Journal of Laboratory Medicine, 2011, 32(7): 768-769.

13. Goh S, Cooper ME. Clinical review: The role of advanced glycation end products in progression and complications of diabetes[J]. The Journal of Clinical Endocrinology and Metabolism, 2008, 93(4): 1143-1152.

14. Falanga V. Wound healing and its impairment in the diabetic foot[J]. The Lancet, 2005, 366(9498): 1736-1743.

15. Reekers JA, Lammer J. Diabetic foot and PAD: the endovascular approach[J]. Diabetes/Metabolism Research and Reviews, 2012, 28(Supplement S1): 36-39.

16. Ailsa S, Jane C. Diabetes and its effects on wound healing[J]. Nursing Standard, 2011, 25(45): 41-47.

17. 邢燁, 袁娜, 韓睿. MicroRNAs在糖尿病潰瘍愈合中作用的研究進(jìn)展[J]. 中國醫(yī)藥導(dǎo)報(bào), 2019, 16(22): 58-61.

Xing Y, Yuan N, Han R. Research progress of the role of MicroRNAs in the healing of diabetic ulcers[J]. China Medical Herald, 2019, 16(22): 58-61.

18. Orapiriyakul W, Young PS, Damiati L, et al. Antibacterial surface modification of titanium implants in orthopaedics[J]. Journal of Tissue Engineering, 2018, 9(8373): 204173141878983.

19. 李甜, 張亞樓, 陳龍, 等. 鏈脲佐菌素誘導(dǎo)C57小鼠1型糖尿病模型的研究[J]. 現(xiàn)代生物醫(yī)學(xué)進(jìn)展, 2014, 14(26): 5031-5033.

20. Zhang Y, Jiang J, Chen Y. Synthesis and antimicrobial activity of polymeric guanidine and biguanidine salts[J]. Polymer, 1999, 40(22): 6189-6198.

21. 單慧慧. 紅霉素配合皮膚護(hù)理治療激素依賴性皮炎療效分析[J]. 中國衛(wèi)生標(biāo)準(zhǔn)管理, 2014, 5(12): 38-40.

Shan HH. Analysis of Therapeutic Effect of Erythromycin Combined with Skin Care Treatment of Hormone Dependent Dermatitis[J]. China Health Standards Management, 2014, 5 (12): 38-40.

22. Wong EHH, Khin MM, Ravikumar V, et al. Modulating antimicrobial activity and mammalian cell biocompatibility with glucosamine-functionalized star polymers[J]. Biomacromolecules,2016, 17(3): 1170-1178.

23. 王曉莉, 王超男, 初彥輝, 等. STZ誘導(dǎo)構(gòu)建1型糖尿病腎病動物模型[J]. 牡丹江醫(yī)學(xué)院學(xué)報(bào), 2014,35(3): 4-7.

Wang HL, Wang CN, Chu YH, et al. STZ induced the establishment of type 1 diabetic nephropathy animal model[J]. Journal of Mudanjiang Medical College, 2014,35(3): 4-7.

24. Godwin JW, Pinto AR, Rosenthal NA. Macrophages are required for adult salamander limb regeneration[J]. Proceedings of the National Academy of Sciences of the United states of America, 2013. 110(23): 9415-9420.


服務(wù)與反饋:
文章下載】【加入收藏
提示:您還未登錄,請登錄!點(diǎn)此登錄
 
友情鏈接  
地址:北京安定門外安貞醫(yī)院內(nèi)北京生物醫(yī)學(xué)工程編輯部
電話:010-64456508  傳真:010-64456661
電子郵箱:[email protected]